Ramelteon SL

DRUG2 trials

Sponsors

Takeda

Conditions

Acute Depressive EpisodeBipolar Disorder

Phase 3

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder

TerminatedNCT01467713

TakedaBipolar Disorder

Start: 2011-12-31End: 2015-03-31Updated: 2016-05-16

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

TerminatedNCT01467700

TakedaAcute Depressive Episode

Start: 2011-12-31End: 2015-03-31Updated: 2016-05-16